NPAS3 Variants in Schizophrenia: A Neuroimaging Study

BMC Medical Genetics - United Kingdom
doi 10.1186/1471-2350-15-37
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Neuroimaging Biomarkers for Early Drug Development in Schizophrenia

Biological Psychiatry
Biological Psychiatry
2014English

PET Neuroimaging Reveals Histone Deacetylase Dysregulation in Schizophrenia

Journal of Clinical Investigation
Medicine
2018English

A Review of Structural Neuroimaging in Schizophrenia: From Connectivity to Connectomics

Frontiers in Human Neuroscience
Mental HealthNeuropsychologyPhysiological PsychologyNeurologyBehavioral NeurosciencePsychiatryBiological Psychiatry
2014English

Neuroimaging Evidence for the Deficit Subtype of Schizophrenia

JAMA Psychiatry
MedicinePsychiatryMental Health
2013English

The Role of Neuroimaging Biomarker in Drug Discovery for Schizophrenia

Folia Pharmacologica Japonica
Pharmacology
2012English

Further Neuroimaging Evidence for the Deficit Subtype of Schizophrenia

JAMA Psychiatry
MedicinePsychiatryMental Health
2015English

Neuroimaging and Other Neurobiological Indices in Schizophrenia: Relationship to Measurement of Functional Outcome

British Journal of Psychiatry
MedicinePsychiatryMental Health
2007English

Isolation and Characterization of Chicken NPAS3

Experimental Neurobiology
Molecular NeuroscienceNeurologyCellular
2010English

Social Cognition in Schizophrenia: A Review Study

Open Journal of Psychiatry
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy